emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Private Group led by Qualium Investissement / Groupe Clinadent (Yanoal)

No EMAT : 106613
Announced Date : 20/01/2021
Type : LBO (Leverage Buy Out)
Deal Value : Yes
Acquirer : Private Group led by Qualium Investissement

Target : Groupe Clinadent (Yanoal)
Country : Hauts-De-Seine
Sector of activity :
  • Health Care Providers > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Clinics and hospitals
  • Health Care Providers > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Specialist Care
Business Description :
Founded in 2016 by Philippe Yachare, Groupe Clinadent operates dental clinics. > Offer includes surgical interventions, orthodontics, dental emergencies, radiology, aesthetics services among others....

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Clinics and hospitals » = 118
  • Number of EMAT Reports / sub-sector « Specialist Care » = 41
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
11/12/2020 Private Group backed by Ardian Growth and BNP Paribas Développement Proteor Rhône * 106378
31/07/2020 Bastide le Confort Médical Technologies Medicales à Domicile (TMAD) France * 106359

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report